首页 工具
登录
购物车
Asimadoline hydrochloride

Asimadoline hydrochloride

产品编号 T4691   CAS 185951-07-9
别名: EMD-61753 hydrochloride, 阿西马朵林盐酸盐

Asimadoline hydrochloride (EMD-61753 hydrochloride) 是一种 κ-阿片(κ-opioid)受体激动剂,对豚鼠和人重组 κ-opioid 的 IC50值分别为 5.6 和 1.2 nM。它可改善糖尿病大鼠的异常性疼痛,具有外周抗炎作用,并有用于肠易激综合征的研究潜力。

TargetMol的所有产品和服务仅用于科学研究,不能被用于人体,我们也不向个人提供产品和服务。
Asimadoline hydrochloride Chemical Structure
Asimadoline hydrochloride, CAS 185951-07-9
规格 价格/CNY 货期 数量
1 mg ¥ 329 现货
2 mg ¥ 477 现货
5 mg ¥ 723 现货
10 mg ¥ 1,160 现货
25 mg ¥ 2,320 现货
50 mg ¥ 3,450 现货
100 mg ¥ 4,890 现货
500 mg ¥ 9,870 现货
1 mL * 10 mM (in DMSO) ¥ 837 现货
其他形式的 Asimadoline hydrochloride:
千万补贴 助力科研
BCA蛋白浓度测定试剂盒限时半价
重组蛋白限时优惠
产品目录号及名称: Asimadoline hydrochloride (T4691)
点击图片重新获取验证码
选择批次  
TargetMol batch loading
更多批次查询请联系客服
生物活性
化学信息
存储 & 溶解度
参考文献
产品描述 Asimadoline hydrochloride (EMD-61753 hydrochloride) is a κ-opioid receptor agonist potentially for the treatment of pruritus. Asimadoline hydrochloride has also been shown to be used in the treatment of irritable bowel syndrome.
靶点活性 κ opioid (human recombinant):1.2 nM (EC50), κ opioid (Guinea pig):5.6 nM (EC50)
体外活性 The IC50 for Asimadoline binding to μ-opioid receptors is 3 μM and to δ-opioid receptors is 0.7 μM. At high concentrations, Asimadoline demonstrates spasmolytic action against 400 μM barium chloride in the rat duodenum (IC50: 4.2 μM), suggesting that Asimadoline may block the direct stimulant effects of barium on smooth muscle through mechanisms that are not identified[1].
体内活性 The metabolism of Asimadoline is rapid and appears similar in animals and man. The absorption rate following oral administration is 80% in rats and >90% in dogs and monkeys. Asimadoline has peripheral anti-inflammatory actions that are partly mediated through an increase in joint fluid substance P levels[1]. Treatment with Asimadoline (5 mg/kg/day i.p.) produces marked (and sustained) attenuation of the disease with all three-time regimes[2].
动物实验 Asimadoline (5 mg/kg/day, n=10 per group) or vehicle (2 mL/kg/day, n=10) is administered to DA rats by i.p. injection twice daily (i) during the primary inflammatory phase (days 1–3); (ii) once the disease is established (days 13–21); or (iii) throughout the entire time course (days 1-21). Non-arthritic control animals receive Asimadoline (5 mg/kg/day, n=5) or vehicle (2 mL/kg/day, n=5) by i.p. injection twice daily. In all cases, disease parameters are assessed. In this experiment, the SP content of joint tissue is assessed only after the rats are killed (day 21)[2].
别名 EMD-61753 hydrochloride, 阿西马朵林盐酸盐
分子量 451.01
分子式 C27H31ClN2O2
CAS No. 185951-07-9

存储

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度

DMSO: 60 mg/mL (133.03 mM), Heating is recommended.

溶液配制表

可选溶剂 浓度 体积 质量 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 2.2172 mL 11.0862 mL 22.1725 mL 55.4311 mL
5 mM 0.4434 mL 2.2172 mL 4.4345 mL 11.0862 mL
10 mM 0.2217 mL 1.1086 mL 2.2172 mL 5.5431 mL
20 mM 0.1109 mL 0.5543 mL 1.1086 mL 2.7716 mL
50 mM 0.0443 mL 0.2217 mL 0.4434 mL 1.1086 mL
100 mM 0.0222 mL 0.1109 mL 0.2217 mL 0.5543 mL

TargetMol Calculator计算器

摩尔浓度计算器
稀释计算器
配液计算器
分子量计算器
=
X
X
X
=
X
=
/
g/mol

输入分子式,点击计算,可计算出产品的分子量。

TargetMol Library Books参考文献

1. Camilleri M, et al. Asimadoline, a κ-Opioid Agonist, and Visceral Sensation. Neurogastroenterol Motil. 2008 Sep; 20(9): 971–979. 2. Binder W, et al. Involvement of substance P in the anti-inflammatory effects of the peripherally selective kappa-opioid asimadoline and the NK1 antagonist GR205171. Eur J Neurosci. 1999 Jun;11(6):2065-72.
Aticaprant PZM21 CTAP(TFA) (103429-32-9 free base) BTRX-335140 Naltrexone hydrochloride Nociceptin (1-13), amide Docusate sodium Asimadoline

相关化合物库

该产品包含在如下化合物库中:
药物功能重定位化合物库 神经退行性疾病化合物库 抗癌药物库 抗癌临床化合物库 GPCR靶点分子库 膜蛋白靶向化合物库 神经信号分子库 临床期小分子药物库 表型筛选靶点鉴定库 内分泌激素分子库

TargetMol Calculator剂量换算

对于不同动物的给药剂量换算,您也可以参考 更多...

TargetMol Calculator 体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。

第一步:请输入动物实验的基本信息
剂量
mg/kg
每只动物体重
g
给药体积
μL
动物数量
第二步:请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
% Tween 80
% ddH2O
计算 重置

技术支持

您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。

Keywords

Asimadoline hydrochloride 185951-07-9 Endocrinology/Hormones GPCR/G Protein Neuroscience Opioid Receptor syndrome bowel diabetic EMD61753 EMD-61753 hydrochloride Asimadoline irritable κ-opioid δ-opioid EMD 61753 inhibit EMD61753 Hydrochloride Asimadoline Hydrochloride EMD-61753 EMD-61753 Hydrochloride μ-opioid allodynia EMD 61753 Hydrochloride Inhibitor 阿西马朵林盐酸盐 inhibitor

 

TargetMol Loading
陶术
生物
TargetMol®中国区唯一合作伙伴
点击进入陶术生物官网陶术生物
联系我们
400-820-0310

上海市静安区江场三路238号8楼